Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

Kizilirmak, Pinar; Uresin, Yagiz; Ozdemir, Oktay; Avci, Burcak; Tokgozoglu, SADBERK; Ongen, Zeki

doi:10.5543/tkda.2016.78006

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

Kizilirmak P., Uresin Y., Ozdemir O., Avci B. K., Tokgozoglu L., Ongen Z.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.45, sa.1, ss.49-66, 2017 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.5543/tkda.2016.78006
Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.49-66
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes.